CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Press Releases Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 12/12/2025 GMT			5-day change	1st Jan Change
193.03 ^USD	-0.72%		+4.73%	+4.57%

12-03	Charles River Laboratories International, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:00 AM
12-03	Charles River Laboratories International Inc - DSA Net Book-to-Bill Improved Each Month Since Q3 2025 - SEC Filing	RE

Press Releases

Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort	12-11	BU
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	12-01	PR
Charles River Laboratories to Present at Evercore Healthcare Conference	12-01	BU
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	11-24	BU
Charles River Laboratories to Present at Jefferies Global Healthcare Conference	11-17	BU
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	11-08	PR
Charles River Laboratories International : Q3 2025 Earnings Presentation	11-05	PU
Charles River: Q3 Earnings Snapshot	11-05	AQ
Charles River Laboratories Announces Third-Quarter 2025 Results	11-05	BU
Charles River Laboratories Provides Update on Strategic Review	11-05	BU
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	10-27	PR
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	10-27	BU
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights	10-24	BU
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development	10-22	BU
Charles River and X Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities	10-21	AQ
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities	10-20	BU
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	10-15	BU
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call	10-14	BU
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing	10-08	BU
Charles River Laboratories Announces Chief Financial Officer Transition	09-16	BU
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer	09-11	BU
Within3 Unveils Launch Intelligence and Know Everything to Transform How Life Sciences Teams Make Critical Decisions	09-09	AQ
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences	09-08	BU
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences	09-03	BU
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing	08-26	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Press Releases

Filters